The development of medications for Parkinson's disease using computational modeling

Mubashir Hassan, Ahmed A. Moustafa

Research output: Chapter in Book / Conference PaperChapter

Abstract

Neuronal computational modeling is considered an important approach to address neurodegenerative disorders like Parkinson's disease. In this chapter, we discuss methods to develop a computational model for potential treatment of Parkinson's disease. The model includes representations for the striatum and subthalamic nucleus as well as known experimental data on neurotransmitters including dopamine and ion channels. The model focuses on simulating neuronal beta oscillations in both striatum and subthalamic nucleus as biomarkers for Parkinson's disease. After simulating Parkinson's disease, we explain how modeling can be used to conduct virtual medication studies to find which parameters normalize striatal and subthalamic nucleus function, which then suggest a treatment for Parkinson's disease. It is therefore hoped that novel computational models will help identify biomarkers and potential treatment for Parkinson's disease.
Original languageEnglish
Title of host publicationComputational Models of Brain and Behavior
EditorsAhmed A. Moustafa
Place of PublicationU.S.
PublisherWiley & Sons
Pages125-138
Number of pages14
ISBN (Electronic)9781119159193
ISBN (Print)9781119159063
DOIs
Publication statusPublished - 2018

Keywords

  • basal ganglia
  • Parkinson's disease
  • corpus striatum
  • brain stimulation

Fingerprint

Dive into the research topics of 'The development of medications for Parkinson's disease using computational modeling'. Together they form a unique fingerprint.

Cite this